News

In a recent episode of the Leaders in Life Sciences podcast, Jayasree Iyer, CEO of the Access to Medicine Foundation, reflects on her career journey and shares her perspective on building partnerships t

We are pleased to spotlight the launch of the COREON Podcast, a new initiative by the Committee on Regulation of Health Research (COREON), featuring our colleagues Olenka van Ardenne and Daniel Groos.

Lygature is proud to announce its involvement in the program management of the CANDLE project. ‘CANDLE offers a unique opportunity to implement data-driven approaches in health research at scale in Europe.’

The European Platform for Neurodegenerative Diseases (EPND) has released its first harmonised biomarker dataset, the ATN dataset, now accessible via the EPND Hub.

Lygature has submitted input to the European Commission’s open consultation on its 2025-2029 Life Sciences Strategy. Our response is now publicly available on the European Commission website. 

Lygature is pleased to announce its official validation as a Research Organization by the European Commission—an important milestone that strengthens our positioning within the European research landscape and opens new avenues for collaboration.

We’re proud to share the first-ever Lygature Impact Report, a milestone in our commitment to advancing healthcare innovation through complex collaborations. 

On 19 March 2025, Lygature hosted its stakeholder event, Lygature LIVE, at Villa Jongerius in Utrecht. This year's theme was ‘Impact’, with the afternoon dedicated to exploring how partnerships influence society and global health.

In February, Lygature participated in a series of events co-organized by the Scientific Community for Discovery of Future Medicines (C4D) aimed at establishing networks for discovering new antibiotics.

The Pediatric Praziquantel Consortium, which Lygature proudly coordinates, has achieved a significant milestone with the first administration of its new pediatric treatment to a preschool-aged child in Uganda.

We are happy to announce that Heleen Knottnerus (Policy Officer Advocacy at Diabetes Association Netherlands and EUPATI fellow) and Laurence Maes (Lead Patient Value at Johnson & Johnson Innovative Medicine) have now been confirmed as speakers for Lygature LIVE. Their duo-presentation at Lygature LIVE will focus on boosting the impact of patient involvement in drug discovery.

For almost two decades, Lygature has been building on its experience with managing complex international partnerships. One core expertise of Lygature's is the management of public-private partnerships in the pre-competitive domain such as the Innovative Health Initiative-funded PREDICTOM project.

We are delighted to announce that Chris De Jonghe, Valorization Director at Oncode Institute, has been confirmed as a speaker for Lygature LIVE. Chris will share her insights on the impact of Oncode Institute and highlight the advantages of its connection with Lygature.

Today, 30 January, on World Neglected Tropical Diseases Day, the World Health Organization (WHO) calls upon the global community to unite, act and eliminate neglected tropical diseases (NTDs).

We are excited to announce that Thera Max-Mos has been confirmed as a speaker at Lygature LIVE, which will take place on 19 March 2025.